Like the situation in bladder cancer, presence of HER4 expression was also independent predictor of favored outcome in breast cancer and the head and neck squamous cell carcinoma (Barnes et al., 2005; Machleidt et al., 2013; De Pauw et al., 2018). The gene discussed is ERBB4; the disease is urinary bladder carcinoma.